Lotus Pharmaceutical Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	5,670	6,030	1,771	1,983	1,605	1,489
Cash & Short-Term Investments	5,670	6,030	1,771	1,983	1,605	1,489
Cash Growth	53.75%	240.51%	-10.71%	23.54%	7.82%	16.61%
Accounts Receivable	5,644	7,435	6,384	4,651	3,266	2,747
Other Receivables	212.43	268.54	233.13	276.24	141.56	53.19
Receivables	5,856	7,703	6,617	4,927	3,407	2,801
Inventory	3,930	3,833	3,775	3,330	3,073	2,208
Other Current Assets	621.13	531.5	489.37	420.4	247.24	284.61
Total Current Assets	16,077	18,098	12,653	10,661	8,333	6,783
Property, Plant & Equipment	3,521	3,666	3,511	3,148	2,642	2,305
Long-Term Investments	3,869	3,594	3,048	2,158	301.73	412.85
Goodwill	6,031	6,127	5,670	5,668	5,586	5,896
Other Intangible Assets	6,128	5,199	5,487	5,910	2,971	3,177
Long-Term Accounts Receivable	125.2	122.73	152.6	-	-	-
Long-Term Deferred Tax Assets	503.89	486.42	411.69	390.12	310.82	364.61
Long-Term Deferred Charges	3,179	2,639	1,878	1,406	891.98	654.1
Other Long-Term Assets	165.99	168.74	180.28	185.33	185.35	161.12
Total Assets	39,600	40,101	32,992	29,526	21,222	19,753
Accounts Payable	1,051	1,070	670.8	1,403	747.55	1,732
Accrued Expenses	0.13	-	3.06	3.57	0.93	2.46
Short-Term Debt	1,517	1,615	510	155.92	1,377	410
Current Portion of Long-Term Debt	4,236	3,390	1,303	59.95	794.9	1,359
Current Portion of Leases	83.06	84.32	70.24	58.99	62.47	40.43
Current Income Taxes Payable	427.91	664.47	436.56	731.15	280.16	226.62
Current Unearned Revenue	171.8	180.9	132.85	183.08	132.01	132.1
Other Current Liabilities	1,382	1,433	1,398	3,297	931.26	980.66
Total Current Liabilities	8,869	8,438	4,524	5,893	4,326	4,883
Long-Term Debt	6,438	8,384	9,519	8,596	4,667	4,948
Long-Term Leases	142.69	194.06	182.2	46.82	43.41	76.58
Long-Term Unearned Revenue	18.53	26.56	45.33	65.92	85.96	111.78
Pension & Post-Retirement Benefits	692.35	673.52	503.28	371.91	502.7	586.86
Long-Term Deferred Tax Liabilities	1,093	1,093	721.2	448.4	304.15	144.69
Other Long-Term Liabilities	173.44	112.17	162.29	235.84	224.03	257.46
Total Liabilities	17,427	18,921	15,658	15,658	10,153	11,008
Common Stock	2,670	2,659	2,650	2,626	2,628	2,454
Additional Paid-In Capital	7,641	7,431	7,131	7,534	8,039	6,799
Retained Earnings	14,740	12,660	8,900	4,823	1,701	353.66
Treasury Stock	-825.36	-48.39	-51.1	-57.35	-57.75	-
Comprehensive Income & Other	-2,054	-1,521	-1,295	-1,058	-1,241	-860.97
Total Common Equity	22,172	21,180	17,334	13,868	11,069	8,745
Shareholders' Equity	22,172	21,180	17,334	13,868	11,069	8,745
Total Liabilities & Equity	39,600	40,101	32,992	29,526	21,222	19,753
Total Debt	12,416	13,667	11,585	8,918	6,944	6,834
Net Cash (Debt)	-6,747	-7,636	-9,814	-6,935	-5,339	-5,345
Net Cash Per Share	-25.73	-28.99	-37.45	-26.50	-20.80	-21.95
Filing Date Shares Outstanding	262.98	265.39	264.47	262.04	262.25	245.35
Total Common Shares Outstanding	262.98	265.39	264.47	262.04	262.25	245.35
Working Capital	7,208	9,660	8,129	4,768	4,007	1,900
Book Value Per Share	84.31	79.81	65.54	52.92	42.21	35.64
Tangible Book Value	10,014	9,855	6,177	2,291	2,512	-327.16
Tangible Book Value Per Share	38.08	37.13	23.36	8.74	9.58	-1.33
Land	587.46	599.33	622.55	622.31	615.49	654.22
Buildings	2,106	2,074	1,888	1,384	1,313	1,012
Machinery	1,984	1,865	1,826	1,547	1,408	1,324
Construction In Progress	585.54	706.38	639.41	1,077	675.22	608.86
Leasehold Improvements	90.53	100.15	71.01	87.87	78.26	85.33

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.